Acute buspirone abolishes the expression of behavioral dopaminergic supersensitivity in mice

Acute buspirone abolishes the expression of behavioral dopaminergic supersensitivity in mice

Autor Queiroz, Claudio Marcos Teixeira de Autor UNIFESP Google Scholar
Alcântara, F.b. Autor UNIFESP Google Scholar
Yagüe, A.m.l. Autor UNIFESP Google Scholar
Bibancos, Theo Autor UNIFESP Google Scholar
Frussa-Filho, Roberto Autor UNIFESP Google Scholar
Instituição Universidade Federal de São Paulo (UNIFESP)
Resumo Previous studies have shown that rats withdrawn from long-term treatment with dopamine receptor blockers exhibit dopaminergic supersensitivity, which can be behaviorally evaluated by enhanced general activity observed in an open-field. Recently, it has been reported that co-treatment with the non-benzodiazepine anxiolytic buspirone attenuates the development of haloperidol-induced dopaminergic supersensitivity measured by open-field behavior of rats. The aims of the present study were: 1) to determine, as previously reported for rats, if mice withdrawn from long-term neuroleptic treatment would also develop dopaminergic supersensitivity using open-field behavior as an experimental paradigm, and 2) to examine if acute buspirone administration would attenuate the expression of this behavioral dopaminergic supersensitivity. Withdrawal from long-term haloperidol treatment (2.5 mg/kg, once daily, for 20 days) induced a significant (30%) increase in ambulation frequency (i.e., number of squares crossed in 5-min observation sessions) but did not modify rearing frequency or immobility duration in 3-month-old EPM-M1 male mice observed in the open-field apparatus. Acute intraperitoneal injection of buspirone (3.0 and 10 but not 1.0 mg/kg, 12-13 animals per group) 30 min before open-field exposure abolished the increase in locomotion frequency induced by haloperidol withdrawal. These data suggest that the open-field behavior of mice can be used to detect dopaminergic supersensitivity, whose expression is abolished by acute buspirone administration.
Assunto Buspirone
Dopaminergic supersensitivity
Tardive dyskinesia
Idioma Inglês
Data 2002-02-01
Publicado em Brazilian Journal of Medical and Biological Research. Associação Brasileira de Divulgação Científica, v. 35, n. 2, p. 237-242, 2002.
ISSN 0100-879X (Sherpa/Romeo, fator de impacto)
Editor Associação Brasileira de Divulgação Científica
Extensão 237-242
Direito de acesso Acesso aberto Open Access
Tipo Artigo
Web of Science WOS:000174281400013
SciELO S0100-879X2002000200013 (estatísticas na SciELO)

Mostrar registro completo

Arquivos deste item

Nome: S0100-879X2002000200013.pdf
Tamanho: 34.91Kb
Formato: PDF

Este item aparece na(s) seguinte(s) coleção(s)